Remove Cardiovascular Disease Remove General Cardiology Remove Myocardial Infarction
article thumbnail

Higher Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation Noted After Spinal Cord Injury

All About Cardiovascular System and Disorders

There are several factors which increase the risk of cardiovascular disease in survivors of spinal cord injury. Higher risk of myocardial infarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Survivors with severe disability had the highest risk. PMID: 17251696.

article thumbnail

How Does Exercise Prevent Heart Disease?

All About Cardiovascular System and Disorders

Exercise in a regular pattern is one of the important life style modifications which everyone can adopt to prevent or delay cardiovascular disease. Exercise helps in various ways for prevention of cardiovascular disease. Maintaining normal blood pressure also reduces the risk of stroke and myocardial infarction.

article thumbnail

Does Fish Oil Supplement Increase Risk of Stroke and Atrial Fibrillation?

All About Cardiovascular System and Disorders

General information is that fish oil supplements are beneficial for cardiovascular health. Recommendation from UK National Institute for Health and Care Excellence is that people with or at high risk of cardiovascular disease consume at least one portion of oily fish a week.

article thumbnail

CLEAR Trial of Bempedoic Acid

All About Cardiovascular System and Disorders

CLEAR trial was a double blind, randomized, placebo controlled trial of patients who were unable or unwilling to take statins due to unacceptable adverse effects and had or were at high risk for cardiovascular disease. CLEAR trial had patients for both primary and secondary prevention of cardiovascular disease.

article thumbnail

Highlights of ACC 2024

Cardiology Update

EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI). Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). of patients in the PCI group compared to 3.4%

Angina 52